Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2021-03-25 Annual Report
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Annual Report 2021
Annual Report Classification · 1% confidence The document is a comprehensive annual report for Karolinska Development for the year 2020. It includes a table of contents, CEO comments, business strategy, financial summaries, and references to the full financial statements, auditor's report, and corporate governance report. It is clearly the full annual report document, not an announcement or a summary. FY 2021
2021-03-25 English
Karolinska Development's portfolio company Modus Therapeutics initiates preparations for listing on Nasdaq First North Growth Market
Capital/Financing Update Classification · 1% confidence The document announces that a portfolio company, Modus Therapeutics, is preparing for an Initial Public Offering (IPO) on Nasdaq First North Growth Market. The purpose of the IPO is explicitly stated as facilitating financing for a clinical development program. This announcement details fundraising/financing activities and capital structure changes related to the subsidiary, which directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it mentions management changes (CFO recruitment), the primary focus and driver of the announcement is the planned listing and financing. It is not a full 10-K, an ER, or a standard regulatory filing (RNS) but a specific corporate action announcement.
2021-03-15 English
Karolinska Developments portföljbolag Modus Therapeutics förbereder notering på Nasdaq First North Growth Market
Capital/Financing Update Classification · 1% confidence The document is an announcement from Karolinska Development AB regarding its portfolio company, Modus Therapeutics, preparing for a listing on Nasdaq First North Growth Market. The core subject is a planned Initial Public Offering (IPO) or listing, which is a significant financing and capital structure event for the subsidiary, intended to fund its clinical development program. This directly relates to fundraising, financing activities, and capital structure changes for the entity being discussed (Modus Therapeutics, announced by the parent company). Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is an announcement about a future financing event.
2021-03-15 Swedish
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding and voting rights for a specific instrument (Aktie SE0002190850) by a holder (Insamlingsstiftelsen för fämjande av medicinsk forskning vid Karolinska Institutet). It explicitly shows the 'Before the transaction' and 'After the transaction' figures for shares and voting rights, culminating in a new percentage holding (9.34%). This structure is characteristic of a notification regarding a change in significant share ownership, which aligns with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be a direct regulatory filing notification rather than a comprehensive report.
2021-03-05 English
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by Karolinska Institutet Holding AB in Karolinska Development AB, specifically crossing a threshold (5%). This is a standard regulatory disclosure for major shareholding notifications.
2021-03-05 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Major shareholding notification') by an entity ('Karolinska Institutet Holding AB') regarding shares in 'Karolinska Development AB'. It explicitly shows the 'Before the transaction' and 'After the transaction' holdings, including the number of shares and resulting voting rights percentages. This directly corresponds to the definition of a Major Shareholding Notification.
2021-03-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.